Official Publications Stem Cell Therapeutics Corp. Xetra
Equities
R5W
CA8585721001
End-of-day quote
Other stock markets
|
||
- EUR | - |
2022 | TCR2 Therapeutics Appoints Chief Business and Strategy Officer | MT |
2021 | Pfizer Deploying Some of Its Covid Cash in Arena Deal -- Analysis | DJ |
Official Publications
No official publication found
- Stock Market
- Equities
- TRIL Stock
- R5W Stock
- News Stem Cell Therapeutics Corp.
- Official Publications